Shanghai Haili Biotechnology Co., Ltd. obtained invention patent

Shanghai Haili Biotechnology Co., Ltd. (hereinafter referred to as the "Company") recently received an invention patent certificate issued by the State Intellectual Property Office of the People's Republic of China. The details are as follows:

Certificate number: No. 3285701

Title of invention: A recombinant porcine circovirus virus-like particle and its preparation method

Patent number: ZL 2015 1 0091995.1

Patent application date: February 28, 2015

Patentee: Shanghai Haili Biotechnology Co., Ltd.

Authorization announcement date: March 8, 2019

Authorization announcement number: CN 104651316 B

Patent term: 20 years (from the filing date)

The acquisition of the above invention patents is the embodiment and extension of the important core technologies obtained by the company's independent research and development. The acquisition of this patent will not have a significant impact on the company's recent operations, but it will help further improve the company's intellectual property protection system, give full play to the technical advantages of independent intellectual property rights, promote technological innovation, and thereby enhance the company's core competitiveness.